Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts

Today, 6:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9)

ACET

10 minute read

Earnings Scheduled For August 10, 2021

By Benzinga Insights

Today, 6:08 AM

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.

ABST

2 minute read

Earnings

Earnings Preview: Cumberland

By Benzinga Insights

Today, 6:08 AM

Cumberland (NASDAQ:CPIX) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.

CPIX

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 6:08 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

2 minute read

News

Cumberland Pharmaceuticals Says Co’s Vibativ Helps Treat Secondary Bacterial Infections In COVID-19 Patients

By Benzinga Newsdesk

Today, 6:08 AM

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of Vibativ® (telavancin) in treating secondary bacterial

CPIX

1 minute read

News

Cumberland Pharmaceuticals Says On June 11 Co Received A Formal Notice From SBA That Full Amount Of Loan Pursuant To PPP Is Forgiven

By Benzinga Newsdesk

Today, 6:08 AM

-8K Filing

CPIX

1 minute read

Uncategorized

Cumberland: Q1 Earnings Insights

By Benzinga Insights

Today, 6:08 AM

Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which beat the estimate of ($0.07).

CPIX

6 minute read

Uncategorized

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

By Shanthi Rexaline

Today, 6:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)

ABBV

9 minute read

Uncategorized

Earnings Scheduled For May 11, 2021

By Benzinga Insights

Today, 6:08 AM

Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter.

ABST

6 minute read

Uncategorized

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings

By Shanthi Rexaline

Today, 6:08 AM

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S.

ABCL